IMM-160

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIMM-160
Drug Alias NameIMM-160
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmuron Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmuron Ltd
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A